Your browser doesn't support javascript.
loading
Plk1-targeted therapies in TP53- or RAS-mutated cancer.
Yim, Hyungshin; Erikson, Raymond L.
Afiliação
  • Yim H; Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-do 426-791, Republic of Korea. Electronic address: hsyim@hanyang.ac.kr.
  • Erikson RL; Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138, USA. Electronic address: erikson@mcb.harvard.edu.
Mutat Res Rev Mutat Res ; 761: 31-39, 2014.
Article em En | MEDLINE | ID: mdl-24630986
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Mutat Res Rev Mutat Res Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Mutat Res Rev Mutat Res Ano de publicação: 2014 Tipo de documento: Article